Jump to main content
Jump to site search

Issue 4, 2013
Previous Article Next Article

Peptide functionalized nanoparticles for nonviral gene delivery

Author affiliations


Much attention has been directed toward improving nonviral gene delivery in order to replace viral vectors and overcome the barriers to clinical gene therapy. Specifically targeting nonviral gene delivery vehicles to the disease tissue can significantly improve their delivery efficiency. Targeting peptides have been developed for growth factor receptors, integrins and tumor vasculature to target cancer, neurotrophin or neurotoxin receptors aiming to give specificity for neurodegenerative disease, airway epithelial cells to target cystic fibrosis and other tissue specific cells and receptors in bone tissue, cornea and dendritic cells. These highly specific, high-affinity peptides were identified using phage display or through rational design, and were evaluated within this review for their potential and ability to improve transfection, highlighting the successful applications of this technology and discussing the features of the design that contribute to this success. It was found that effective peptide targeting of gene delivery relied both on peptide ligand performance and on nonviral vectors that exploit the appropriate intracellular trafficking mechanisms.

Graphical abstract: Peptide functionalized nanoparticles for nonviral gene delivery

Back to tab navigation

Publication details

The article was received on 15 Jul 2012, accepted on 12 Oct 2012 and first published on 06 Nov 2012

Article type: Review Article
DOI: 10.1039/C2SM26633D
Citation: Soft Matter, 2013,9, 985-1004
  •   Request permissions

    Peptide functionalized nanoparticles for nonviral gene delivery

    R. M. Levine, C. M. Scott and E. Kokkoli, Soft Matter, 2013, 9, 985
    DOI: 10.1039/C2SM26633D

Search articles by author